1. Home
  2. SRZN

as 11-13-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Founded: 2015 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 38.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 30.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -16.91 EPS Growth: N/A
52 Week Low/High: $5.55 - $16.19 Next Earning Date: 11-06-2024
Revenue: $10,000,000 Revenue Growth: -20.00%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

SRZN Daily Stock ML Predictions

Share on Social Networks: